MedWatch

Streamlining to ensure success for ALK: "We need a solid foundation"

Danish allergy group ALK has invested more efforts than ever in simplifying processes and streamlining the company. The changes involve expenses in the short-term but will hopefully help ALK fulfill the long-term goal to match other pharma companies.

Carsten Hellmann, CEO, ALK | Foto: Gregers Tycho/ERH

Danish ALK is currently investing several resources, time and money in streamlining the company and preparing for growth in the years to come.

"We are in the middle of a major clean-up to ensure that new top line results don't affect the bottom line negatively because our basic business is too weak. ALK needs a solid foundation so we can focus on the profitable areas," says CEO Carsten Hellmann to MedWatch.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier